These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35240549)
1. Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience. Tirrò E; Martorana F; Micale G; Inzerilli N; Carciotto R; Romano C; Longhitano C; Motta G; Lanzafame K; Stella S; Massimino M; Vitale SR; Salvatorelli L; Magro G; Manzella L; Vigneri P Pathol Res Pract; 2022 Apr; 232():153820. PubMed ID: 35240549 [TBL] [Abstract][Full Text] [Related]
2. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing. Andersson C; Fagman H; Hansson M; Enlund F Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750 [TBL] [Abstract][Full Text] [Related]
3. Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics. Jour G; Scarborough JD; Jones RL; Loggers E; Pollack SM; Pritchard CC; Hoch BL Hum Pathol; 2014 Aug; 45(8):1563-71. PubMed ID: 24908143 [TBL] [Abstract][Full Text] [Related]
4. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope. Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741 [TBL] [Abstract][Full Text] [Related]
5. Novel fusion sarcomas including targetable NTRK and ALK. Chen T; Wang Y; Goetz L; Corey Z; Dougher MC; Smith JD; Fox EJ; Freiberg AS; Flemming D; Fanburg-Smith JC Ann Diagn Pathol; 2021 Oct; 54():151800. PubMed ID: 34464935 [TBL] [Abstract][Full Text] [Related]
6. Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience. Cote GM; He J; Choy E Oncologist; 2018 Feb; 23(2):234-242. PubMed ID: 28860410 [TBL] [Abstract][Full Text] [Related]
7. Small Round Blue Cell Sarcoma Other Than Ewing Sarcoma: What Should an Oncologist Know? Davis JL; Rudzinski ER Curr Treat Options Oncol; 2020 Sep; 21(11):90. PubMed ID: 32875423 [TBL] [Abstract][Full Text] [Related]
8. The clinical utility of next-generation sequencing for bone and soft tissue sarcoma. Gusho CA; Weiss MC; Lee L; Gitelis S; Blank AT; Wang D; Batus M Acta Oncol; 2022 Jan; 61(1):38-44. PubMed ID: 34686105 [No Abstract] [Full Text] [Related]
9. Genomic Profiling and Clinical Outcomes of Targeted Therapies in Adult Patients with Soft Tissue Sarcomas. Kokkali S; Georgaki E; Mandrakis G; Valverde C; Theocharis S Cells; 2023 Nov; 12(22):. PubMed ID: 37998367 [TBL] [Abstract][Full Text] [Related]
10. Determination of COL1A1-PDGFB breakpoints by next-generation sequencing in the molecular diagnosis of dermatofibrosarcoma protuberans. Zhu R; Yan J; Li B; Tan F; Yan W; Shen J; Fan L; Ding L; Chen Y; Tang Y; Liu Y; Bai Y Exp Mol Pathol; 2021 Oct; 122():104672. PubMed ID: 34371012 [TBL] [Abstract][Full Text] [Related]
11. Spindle and Round Cell Sarcoma With EWSR1-PATZ1 Gene Fusion: A Sarcoma With Polyphenotypic Differentiation. Chougule A; Taylor MS; Nardi V; Chebib I; Cote GM; Choy E; Nielsen GP; Deshpande V Am J Surg Pathol; 2019 Feb; 43(2):220-228. PubMed ID: 30379650 [TBL] [Abstract][Full Text] [Related]
12. Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A loss. Lin DI; Hemmerich A; Edgerly C; Duncan D; Severson EA; Huang RSP; Ramkissoon SH; Connor YD; Shea M; Hecht JL; Ali SM; Vergilio JA; Ross JS; Elvin JA Gynecol Oncol; 2020 May; 157(2):357-366. PubMed ID: 32156473 [TBL] [Abstract][Full Text] [Related]
13. Is There Value in Molecular Profiling of Soft-Tissue Sarcoma? Italiano A Curr Treat Options Oncol; 2018 Dec; 19(12):78. PubMed ID: 30523434 [TBL] [Abstract][Full Text] [Related]
14. Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors. Szurian K; Kashofer K; Liegl-Atzwanger B Pathobiology; 2017; 84(6):323-338. PubMed ID: 28817827 [TBL] [Abstract][Full Text] [Related]
15. Superficial sarcomas with CIC rearrangement are aggressive neoplasms: A series of eight cases. Ko JS; Marusic Z; Azzato EM; Farkas DH; Van Arnam J; Seiwerth S; Fritchie K; Patel RM; Rubin BP; Billings SD J Cutan Pathol; 2020 Jun; 47(6):509-516. PubMed ID: 32026485 [TBL] [Abstract][Full Text] [Related]
16. What Would Next Generation Sequencing Bring to the Diagnosis and Treatment of Sarcomas? A Series of 20 Cases, a Single Institution's Experience. Kulaç İ; Bulutay P; Meriçöz ÇA Turk Patoloji Derg; 2021; 37(3):226-232. PubMed ID: 34514574 [TBL] [Abstract][Full Text] [Related]
17. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss. Lazo de la Vega L; Hovelson DH; Cani AK; Liu CJ; McHugh JB; Lucas DR; Thomas DG; Patel RM; Tomlins SA Hum Pathol; 2016 Dec; 58():161-170. PubMed ID: 27664537 [TBL] [Abstract][Full Text] [Related]